信使rna - 1010产生强烈的免疫反应st all four WHO-recommended flu strains
The drugmaker expects to expand its research pipeline from six to 12 over next 18 months
The study will evaluate the ability of MSCopilot to identify early signs of disability worsening
The research grant will help to identify drug candidates for the treatment of the disease
NSCLC is the most common type of lung cancer, representing up to 85% of diagnoses
The mid-stage study of the candidate is expected to begin in the fourth quarter of 2023
The agreement will focus on the development of bispecifics, cell therapies and cancer vaccines
The late-stage study has been evaluating the drug against Johnson & Johnson’s Stelara
Approximately 10 million people worldwide are affected by the inflammatory disease
Adopting a creative IP approach towards biotech clustersWhy big pharma paradigm needs to change
A unique ecosystemHow life science and healthcare clusters are driving innovation
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
IO Biotech announces new data supporting its therapeutic cancer vaccineThe vaccine showed promise when used in combination with Merck & Co’s Keytruda
NIHR awards £2.3m for AI study to improve radiotherapy for lung cancerThe AI tool is expected to help doctors plan each patient’s radiotherapy treatment
ICR study supports used of new radioactive treatment for advanced prostate cancerExperts are calling for NICE to assess if the treatment should be made available on the NHS
MIT researchers design more powerful RNA vaccines for COVID-19The new type of RNA vaccine was shown to produce a stronger immune response at a lower dose
Seagen and Nurix announce oncology partnership worth over $3.4bnThe collaboration will focus on advancing a new class of medicines for use in cancer
AstraZeneca shares positive phase 3 results for Tagrisso combination in lung cancerAn estimated 2.2 million people worldwide are diagnosed with lung cancer each year
Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseasesThe collaboration will focus on advancing three programmes across the next three years
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life SciencesCaulfield served as chief scientist at Genomics England, working on the 100,000 Genomes Project
AZ appoints Susan Galbraith as executive vice president, oncology R&DGalbraith’s appointment into the role follows the passing of José Baselga earlier this year
AZ appoints Alexion’s Aradhana Sarin as chief financial officerSarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals
Doina Ionescu elected to ABPI’s board of directorsIonescu is managing director and general manager for Merck Healthcare UK and Ireland
CureVac taps Klaus Edvardsen for chief development officer roleEdvardsen joins the German biopharma company from Merck KGaA
No results were found
Wallace Health is a healthcare and medical content agency with a successful track record of delivering web content, content marketing...
